Cargando…

Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?

All drugs have both favorable therapeutic and untoward adverse effects. Conventional opioid analgesics possess both analgesia and adverse reactions, such as nausea, vomiting, and respiratory depression. The opioid ligand binds to µ opioid receptor and non-selectively activates two intracellular sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ok, Hwoe Gyeong, Kim, Su Young, Lee, Su Jung, Kim, Tae Kyun, Huh, Billy K, Kim, Kyung Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Pain Society 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904350/ https://www.ncbi.nlm.nih.gov/pubmed/29686804 http://dx.doi.org/10.3344/kjp.2018.31.2.73

Ejemplares similares

Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults
por: Lambert, David, et al.
Publicado: (2020)

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
por: Singla, Neil, et al.
Publicado: (2017)

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy
por: Bergese, Sergio D, et al.
Publicado: (2019)

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy
por: Viscusi, Eugene R, et al.
Publicado: (2019)

APOLLO‐2: A Randomized, Placebo and Active‐Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein–Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty
por: Singla, Neil K., et al.
Publicado: (2019)

Oliceridine- Opioid of the 21(st) Century
por: Goudra, Basavana
Publicado: (2022)

Opioids, sleep, analgesia and respiratory depression: Their convergence on Mu (μ)-opioid receptors in the parabrachial area
por: Lynch, Nicole, et al.
Publicado: (2023)

Extraspinal Percutaneous Osteoplasty for the Treatment of Painful Bony Metastasis
por: Lee, Jae-Heon, et al.
Publicado: (2018)

Pharmacological Advances in Opioid Therapy: A Review of the Role of Oliceridine in Pain Management
por: Kaye, Alan D., et al.
Publicado: (2021)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Analgesia linked to Nav1.7 loss of function requires µ- and δ-opioid receptors
por: Pereira, Vanessa, et al.
Publicado: (2018)

Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
por: Yang, Yin, et al.
Publicado: (2018)

Can denosumab be a substitute, competitor, or complement to bisphosphonates?
por: Kim, Su Young, et al.
Publicado: (2017)

The Effects of Thoracic Epidural Analgesia during Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma
por: Choi, Eun-Ji, et al.
Publicado: (2018)

Hydrogen sulphide induces μ opioid receptor-dependent analgesia in a rodent model of visceral pain
por: Distrutti, Eleonora, et al.
Publicado: (2010)

Effects of Intraperitoneal and Intrathecal Morphine Analgesia on the Expression of μ-Opioid Receptors in Bone Cancer Pain Rats
por: Liu, Wei, et al.
Publicado: (2019)

Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction
por: Sadee, Wolfgang, et al.
Publicado: (2022)

Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects
por: Kliewer, A., et al.
Publicado: (2019)

Quantitative Detection of µ Opioid Receptor: Western Blot Analyses Using µ Opioid Receptor Knockout Mice
por: Kasai, Shinya, et al.
Publicado: (2011)

Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor
por: Perez-Aguilar, Jose Manuel, et al.
Publicado: (2012)

Seasonal Variation in the Brain μ-Opioid Receptor Availability
por: Sun, Lihua, et al.
Publicado: (2021)

The effect of µ-opioid receptor activation on GABAergic neurons in the spinal dorsal horn
por: Kim, Yoo Rim, et al.
Publicado: (2018)

Pharmacological Profiles of Oligomerized μ-Opioid Receptors
por: Lee, Cynthia Wei-Sheng, et al.
Publicado: (2013)

μ-Opioid receptor desensitization: homologous or heterologous?
por: Llorente, Javier, et al.
Publicado: (2012)

Neuropsychological Functions of μ- and δ-Opioid Systems
por: Polunina, Anna G., et al.
Publicado: (2013)

Structural insights into μ-opioid receptor activation
por: Huang, Weijiao, et al.
Publicado: (2015)

How μ-Opioid Receptor Recognizes Fentanyl
por: Vo, Quynh N., et al.
Publicado: (2020)

How μ-Opioid Receptor Recognizes Fentanyl
por: Vo, Quynh N., et al.
Publicado: (2020)

How μ-opioid receptor recognizes fentanyl
por: Vo, Quynh N., et al.
Publicado: (2021)

Expression of µ-Opioid Receptor in CA1 Hippocampal Astrocytes
por: Nam, Min-Ho, et al.
Publicado: (2018)

Oliceridine and its potential to revolutionize GI endoscopy sedation
por: Goudra, Basavana, et al.
Publicado: (2020)

A Dive Into Oliceridine and Its Novel Mechanism of Action
por: Shah, Anjali, et al.
Publicado: (2021)

Response of the μ-opioid system to social rejection and acceptance
por: Hsu, David T, et al.
Publicado: (2013)

μ Opioid receptor: novel antagonists and structural modeling
por: Kaserer, Teresa, et al.
Publicado: (2016)

State-dependent μ-opioid modulation of social motivation
por: Loseth, Guro E., et al.
Publicado: (2014)

Cellular tolerance at the µ-opioid receptor is phosphorylation dependent
por: Arttamangkul, Seksiri, et al.
Publicado: (2018)

Methylnaltrexone: Peripherally Acting µ-Opioid Receptor Antagonist
por: Uritsky, Tanya J.
Publicado: (2019)

Activation mechanism of the μ-opioid receptor by an allosteric modulator
por: Kaneko, Shun, et al.
Publicado: (2022)

Neuron-restrictive silencer factor–mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain
por: Zhu, Chao, et al.
Publicado: (2017)

Search for the FCNC’s $B^0_s \to µ^+µ^−$ and $B^0 \to µ^+µ^−$ with the LHCb spectrometer
por: Martínez Santos, D
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6ol45ui8ifi5skt6t9l975e56j